Inhibitors targeting EZH2, a subunit of the polycomb complex that coordinates chromatin remodeling in conjunction with the BAF complex, are available [27]; however, they have not been clinically effective in SS [28]. The gene discussed is BANF1; the disease is synovial sarcoma.